Check brain and behavior markers during sulforaphane in autism
Part of Mental health clinical trials.
This study tests whether “digital biomarkers” (measurable signs from digital devices) change during treatment with sulforaphane, which is found in certain broccoli extracts. It may help researchers better understand which signals track response in young men with autism.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of autism (“autistic disorder,” not another autism label)
- You are a male age 13 to 30
- You previously participated in the earlier study NCT02677051
- You have not started or continued Avmacol or similar broccoli-extract products since leaving that double-blind study
- A parent or legal guardian can consent for you (if applicable)
- You can attend all study visits and follow the study treatment plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an antioxidant supplement (something that fights cell damage) can help children with autism. It lasts 3 months and requires that the child stays on their current treatments without changes.
This study looks at blood samples from children (and sometimes parents) to see if certain protein patterns can help identify or better understand autism spectrum disorder. The results could support finding “biomarkers,” which are measurable signs that may guide future research or care.
This trial is looking at the connection between the gut and autism. It tests whether certain gut bacteria and the gut's protective barrier are different in children with autism and gastrointestinal issues. This could help find new ways to improve symptoms.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This Phase 2 study tests whether a single dose of N-acetylcysteine can improve “restricted and repetitive behaviors” in children with autism. It’s meant for kids who are stable and still in early puberty stages.
This study tests whether a combination of stem cell therapy, gut microbiome restoration (using specially prepared stool), and dietary changes can improve autism symptoms, communication, social behavior, and digestive issues. Researchers believe gut health and immune system problems may contribute to autism, and this trial explores whether treating these areas helps.
Hear when a new Autism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.